Biotech Innovation and Entrepreneurship by Noubar Afeyan
Noubar Afeyan notes science involves ongoing steps to resolve uncertainty
Science should be considered as a dynamic activity rather than a static body of facts, according to Noubar Afeyan. In a recent statement, Afeyan cautioned against treating science as a final or ...
Noubar Afeyan: New drug research challenges views on scientific progress and federal funding
Innovative pharmaceuticals are challenging long-held assumptions about the nature of scientific advancement.
Noubar Afeyan drew attention to a recent report from the New York Times, which ...
Noubar Afeyan notes evolving AI roles and concept of polyintelligence
Noubar Afeyan participated in a conversation with Trevor Noah at the Skoll World Forum, focusing on the developments and responsibilities present in the current technological era. The discussion ...
Noubar Afeyan calls for action after Ruben Vardanyans imprisonment
Noubar Afeyan has publicly addressed the recent prison sentence of Ruben Vardanyan, advocating for international attention and response. Ruben Vardanyan, a longstanding partner in philanthropy ...
Noubar Afeyan stresses importance of testing scientific skepticism
Noubar Afeyan, a prominent figure in the biotechnology industry and co-founder of Moderna, emphasizes the critical role of scientific skepticism as a catalyst for advancement. In a recent tweet, ...
Noubar Afeyan highlights U.S. shift from medical advances
Noubar Afeyan, co-founder and chairman of Moderna, expresses concerns about decreasing focus on medical innovations in the United States. Afeyan points out that the United States, historically a ...
